DK1750664T3 - Intravitreale implantater i forbindelse med fotodynamisk terapi til at forbedre syn - Google Patents

Intravitreale implantater i forbindelse med fotodynamisk terapi til at forbedre syn

Info

Publication number
DK1750664T3
DK1750664T3 DK05738844T DK05738844T DK1750664T3 DK 1750664 T3 DK1750664 T3 DK 1750664T3 DK 05738844 T DK05738844 T DK 05738844T DK 05738844 T DK05738844 T DK 05738844T DK 1750664 T3 DK1750664 T3 DK 1750664T3
Authority
DK
Denmark
Prior art keywords
photodynamic therapy
improve vision
intravitreal implants
implants associated
intravitreal
Prior art date
Application number
DK05738844T
Other languages
Danish (da)
English (en)
Inventor
Scott M Whitcup
James A Burke
David V Weinberg
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/837,348 external-priority patent/US20050244466A1/en
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of DK1750664T3 publication Critical patent/DK1750664T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
DK05738844T 2004-04-30 2005-04-27 Intravitreale implantater i forbindelse med fotodynamisk terapi til at forbedre syn DK1750664T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/837,348 US20050244466A1 (en) 2004-04-30 2004-04-30 Photodynamic therapy in conjunction with intraocular implants
US11/112,523 US20050244500A1 (en) 2004-04-30 2005-04-22 Intravitreal implants in conjuction with photodynamic therapy to improve vision
PCT/US2005/014201 WO2005110365A1 (en) 2004-04-30 2005-04-27 Intravitreal implants in conjunction with photodynamic therapy to improve vision

Publications (1)

Publication Number Publication Date
DK1750664T3 true DK1750664T3 (da) 2009-11-02

Family

ID=34966870

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05738844T DK1750664T3 (da) 2004-04-30 2005-04-27 Intravitreale implantater i forbindelse med fotodynamisk terapi til at forbedre syn

Country Status (10)

Country Link
US (1) US20050244500A1 (de)
EP (1) EP1750664B1 (de)
JP (1) JP2007535540A (de)
AU (1) AU2005244213B2 (de)
BR (1) BRPI0509456A (de)
CA (1) CA2565249A1 (de)
DE (1) DE602005015439D1 (de)
DK (1) DK1750664T3 (de)
ES (1) ES2327249T3 (de)
WO (1) WO2005110365A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
CA2876822C (en) * 2003-08-27 2015-11-17 David Shima Combination therapy for the treatment of ocular neovascular disorders
US8685435B2 (en) 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
US8142388B2 (en) * 2006-10-30 2012-03-27 Gomez Mario P Apparatus to facilitate removal of cataracts of from the eyes
WO2008098299A1 (en) * 2007-02-14 2008-08-21 Opto Global Holdings Pty Ltd Methods and systems of treating age-related macular degeneration
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US8349005B2 (en) 2011-01-03 2013-01-08 Masatoshi Murata Method for burying implant to choroid
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
JP6100008B2 (ja) 2013-02-06 2017-03-22 正敏 村田 生体用インプラント
MX368730B (es) 2013-02-18 2019-10-14 Vegenics Pty Ltd Moleculas que unen ligando y usos de las mismas.
MX2016000364A (es) 2013-07-12 2016-05-09 Ophthotech Corp Metodos para tratar o prevenir afecciones oftalmologicas.
MY176039A (en) * 2013-11-15 2020-07-22 Allergan Inc Methods of treatment of ocular conditions with a sustained drug delivery implant
EP3677229A1 (de) 2014-05-29 2020-07-08 Glaukos Corporation Implantate mit funktionen der kontrollierten arzneimittelfreisetzung
EP3313466B1 (de) * 2015-06-24 2024-08-07 Healionics Corporation Injizierbare poröse vorrichtung zur behandlung von trockener und nasser altersbedingter makuladegeneration oder diabetischer retinopathie
CN106620893B (zh) * 2015-07-23 2021-07-30 爱博诺德(北京)医疗科技股份有限公司 用于眼部疾病光治疗的材料
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US11564833B2 (en) 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
AU2017252294B2 (en) 2016-04-20 2021-12-02 Dose Medical Corporation Bioresorbable ocular drug delivery device
CN113101530B (zh) * 2021-04-14 2022-09-30 中国人民解放军陆军特色医学中心 一种通过无线充电激活玻璃体腔植入性发光二极管的系统

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
SE390255B (sv) * 1974-02-18 1976-12-13 N G Y Torphammar Upprullningsanordning foretredesvis for ett sekerhetsbelte i ett fordon
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4304765A (en) * 1980-10-14 1981-12-08 Alza Corporation Ocular insert housing steroid in two different therapeutic forms
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
JPS58126435U (ja) * 1982-02-19 1983-08-27 オリンパス光学工業株式会社 Ｔｔｌオ−トストロボ用絞り制御回路
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4521210A (en) * 1982-12-27 1985-06-04 Wong Vernon G Eye implant for relieving glaucoma, and device and method for use therewith
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4668506A (en) * 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
US4959217A (en) * 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
US4853224A (en) * 1987-12-22 1989-08-01 Visionex Biodegradable ocular implants
US4997652A (en) * 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants
US4968715A (en) * 1988-07-06 1990-11-06 Health Research, Inc. Use of purified hematoporphyrin trimers in photodynamic therapy
US5190966A (en) * 1988-07-06 1993-03-02 Health Research, Inc. Purified hematoporphyrin dimers and trimers useful in photodynamic therapy
US5002962A (en) * 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
US5093349A (en) * 1988-07-20 1992-03-03 Health Research Inc. Photosensitizing agents
US5198460A (en) * 1988-07-20 1993-03-30 Health Research Inc. Pyropheophorbides and their use in photodynamic therapy
US5457183A (en) * 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US4935498A (en) * 1989-03-06 1990-06-19 Board Of Regents, The University Of Texas System Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
US5171741A (en) * 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
US5173504A (en) * 1989-04-21 1992-12-22 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
US5503721A (en) * 1991-07-18 1996-04-02 Hri Research, Inc. Method for photoactivation
US5164188A (en) * 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
US5075115A (en) * 1990-04-02 1991-12-24 Fmc Corporation Process for polymerizing poly(lactic acid)
US5232844A (en) * 1990-05-15 1993-08-03 New York Blood Center Photodynamic inactivation of viruses in cell-containing compositions
KR0185215B1 (ko) * 1990-11-30 1999-05-01 요시다 쇼오지 서방성 안구삽입용 약제
IT1263116B (it) * 1992-04-09 1996-07-30 Rotta Research Lab Derivati basici dell'acido glutammico ed acido aspartico, procedimento per la loro preparazione e loro uso farmaceutico
US5655832A (en) * 1992-04-16 1997-08-12 Tir Technologies, Inc. Multiple wavelength light processor
US5244914A (en) * 1992-04-27 1993-09-14 American Cyanamid Company Stable porfimer sodium compositions and methods for their manufacture
US6217869B1 (en) * 1992-06-09 2001-04-17 Neorx Corporation Pretargeting methods and compounds
US5770589A (en) * 1993-07-27 1998-06-23 The University Of Sydney Treatment of macular degeneration
US5443505A (en) * 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
DE4403326C1 (de) * 1994-02-03 1995-06-22 Hans Reinhard Prof Dr Koch Intraokulare Linsenanordnung zur Astigmatismuskorrektur
US5798349A (en) * 1994-03-14 1998-08-25 The General Hospital Corporation Use of green porphyrins to treat neovasculature in the eye
US6270492B1 (en) * 1994-09-09 2001-08-07 Cardiofocus, Inc. Phototherapeutic apparatus with diffusive tip assembly
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US6369116B1 (en) * 1995-06-02 2002-04-09 Oculex Pharmaceuticals, Inc. Composition and method for treating glaucoma
JP2961074B2 (ja) * 1995-09-06 1999-10-12 明治製菓株式会社 光化学療法用の新生血管閉塞剤
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
US6270749B1 (en) * 1996-12-11 2001-08-07 Pharmacyclics, Inc. Use of Texaphyrin in ocular diagnosis and therapy
US6274614B1 (en) * 1997-02-11 2001-08-14 Qlt Inc. Methods, compositions and articles for reducing or preventing the effects of inflammation
CA2300154C (en) * 1997-08-11 2008-07-08 Allergan Sales, Inc. Sterile bioerodible implant device with improved biocompatability and method
AU4645099A (en) * 1998-07-09 2000-02-01 Yoram Harth Apparatus and method for efficient high energy photodynamic therapy of acne vulgaris and seborrhea
US6290713B1 (en) * 1999-08-24 2001-09-18 Thomas A. Russell Flexible illuminators for phototherapy
US6317616B1 (en) * 1999-09-15 2001-11-13 Neil David Glossop Method and system to facilitate image guided surgery
US6331313B1 (en) * 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US6443976B1 (en) * 1999-11-30 2002-09-03 Akorn, Inc. Methods for treating conditions and illnesses associated with abnormal vasculature
EP1253943B1 (de) * 2000-02-10 2008-09-03 MASSACHUSETTS EYE & EAR INFIRMARY Photodynamische therapie zur behandlung von augenerkrankungen
AR032151A1 (es) * 2000-03-24 2003-10-29 Novartis Ag Uso de un farmaco anti-angiogenico en conjunto con un agente fotosensible para la preparacion de un medicamento para el tratamiento fotodinamico mejorado de la neovasculatura indeseada
AU2002248284A1 (en) * 2000-11-01 2002-08-06 Allergan, Inc. Compositions for treatment of ocular neovascularization
US20030082183A1 (en) * 2000-11-01 2003-05-01 Wheeler Larry A. Methods and compositions for treatment of ocular neovascularization and neural injury
DK1339438T3 (da) * 2000-11-29 2006-02-13 Allergan Inc Forebyggelse af transplantatafvisning i ojet
AU2002233092A1 (en) * 2001-02-15 2002-08-28 Qlt Inc. Reduction or prevention of pdt related inflammation
ES2271301T3 (es) * 2001-07-23 2007-04-16 Alcon, Inc. Dispositivo de suministro de farmaco oftalmico.
US20030118657A1 (en) * 2001-12-04 2003-06-26 West Jennifer L. Treatment of disease states characterized by excessive or inappropriate angiogenesis
US6899717B2 (en) * 2002-09-18 2005-05-31 Allergan, Inc. Methods and apparatus for delivery of ocular implants
JP2006507368A (ja) * 2002-09-29 2006-03-02 サーモディックス，インコーポレイティド ステロイド含有治療剤の網膜下投与方法；脈絡膜及び網膜に薬力学作用を局在化するための方法；並びに網膜疾患の治療及び／又は予防のための関連する方法
AU2005292259A1 (en) * 2004-10-01 2006-04-13 Merck & Co., Inc. Compositions and methods for treating ophthalmic diseases

Also Published As

Publication number Publication date
ES2327249T3 (es) 2009-10-27
EP1750664B1 (de) 2009-07-15
DE602005015439D1 (de) 2009-08-27
JP2007535540A (ja) 2007-12-06
AU2005244213A1 (en) 2005-11-24
AU2005244213B2 (en) 2010-06-17
CA2565249A1 (en) 2005-11-24
EP1750664A1 (de) 2007-02-14
US20050244500A1 (en) 2005-11-03
BRPI0509456A (pt) 2007-09-04
WO2005110365A1 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
DK1750664T3 (da) Intravitreale implantater i forbindelse med fotodynamisk terapi til at forbedre syn
EP1730148A4 (de) Aminobenzoxazole als therapeutische mittel
DE502005007353D1 (de) Zervikale zwischenwirbelprothese
ZA200804918B (en) Therapeutic vaccine
EP1962961A4 (de) Demikörper: dimerisations-aktivierte therapeutische mittel
GB0526291D0 (en) Therapeutic method
IS8023A (is) Samsett meðferð til að meðhöndla ónæmisbólgusjúkdóma
DK1765859T3 (da) Annexiner, derivater deraf og annexin-cys varianter samt terapeutiske og diagnostiske anvendelser deraf
GB0524149D0 (en) Surround vision
IL177155A0 (en) Therapeutic combinations
EP1896081A4 (de) Menschliche granulozyten-kolonie-stimulierende faktor-isoformen
DE602005017683D1 (de) Winkelverstellvorrichtung
GB0417481D0 (en) Combination therapy
GB0428180D0 (en) Combination therapy
EP1890761A4 (de) Verfahren zur verstärkung der lipolyse
GB0507003D0 (en) Therapeutic
GB0424339D0 (en) Combination therapy
GB0518720D0 (en) Therapeutic combination
DE602005003586D1 (de) Verbesserte brillen
GB0417558D0 (en) Novel combination therapy
GB0416548D0 (en) Improvements relating to pool heaters
GB2418496B (en) Improvements in or relating to eyewear
GB0427882D0 (en) Therapeutic uses for honey
GB0421438D0 (en) Combination therapy
GB0421436D0 (en) Combination therapy